These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 30986272)
1. Correction: The role of AKT and FOXO3 in preventing ovarian toxicity induced by cyclophosphamide. Zhang BF; Hu Y; Liu X; Cheng Z; Lei Y; Liu Y; Zhao X; Mu M; Yu L; Cheng ML PLoS One; 2019; 14(4):e0215616. PubMed ID: 30986272 [TBL] [Abstract][Full Text] [Related]
2. The role of AKT and FOXO3 in preventing ovarian toxicity induced by cyclophosphamide. Zhang BF; Hu Y; Liu X; Cheng Z; Lei Y; Liu Y; Zhao X; Mu M; Yu L; Cheng ML PLoS One; 2018; 13(8):e0201136. PubMed ID: 30071053 [TBL] [Abstract][Full Text] [Related]
3. Correction: Pre-Treatment with Amifostine Protects against Cyclophosphamide-Induced Disruption of Taste in Mice. Mukherjee N; Carroll BL; Spees JL; Delay ER PLoS One; 2013; 8(7):. PubMed ID: 29220848 [TBL] [Abstract][Full Text] [Related]
4. Correction: How cyclophosphamide at environmentally relevant concentration influences Daphnia magna life history and its proteome. Grzesiuk M; Mielecki D; Pilżys T; Garbicz D; Marcinkowski M; Grzesiuk E PLoS One; 2018; 13(5):e0197416. PubMed ID: 29746575 [TBL] [Abstract][Full Text] [Related]
5. Correction: Correction: AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake. PLOS ONE Staff PLoS One; 2016; 11(5):e0155168. PubMed ID: 28886011 [TBL] [Abstract][Full Text] [Related]
6. Correction: Opposing Effects of PI3K/Akt and Smad-Dependent Signaling Pathways in NAG-1-Induced Glioblastoma Cell Apoptosis. Zhang Z; Wu L; Wang J; Li G; Feng D; Zhang B; Li L; Yang J; Ma L; Qin H PLoS One; 2018; 13(10):e0205391. PubMed ID: 30281640 [TBL] [Abstract][Full Text] [Related]
7. Correction: Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF/Akt/eNOS pathway activation. Wang B; Yang Q; Bai WW; Xing YF; Lu XT; Sun YY; Zhao YX PLoS One; 2019; 14(8):e0220845. PubMed ID: 31369643 [TBL] [Abstract][Full Text] [Related]
8. Correction: Anticoagulation Knowledge Tool (AKT): Further evidence of validity in the Italian population. Magon A; Arrigoni C; Roveda T; Grimoldi P; Dellafiore F; Moia M; Obamiro KO; Caruso R PLoS One; 2018; 13(11):e0204534. PubMed ID: 30439943 [TBL] [Abstract][Full Text] [Related]
9. Correction: Blood type, ABO genetic variants, and ovarian cancer survival. PLOS ONE Staff PLoS One; 2017; 12(5):e0178965. PubMed ID: 28558036 [TBL] [Abstract][Full Text] [Related]
10. Correction: The hMLH1 -93G>A Polymorphism and Risk of Ovarian Cancer in the Chinese Population. Niu L; Li S; Liang H; Li H PLoS One; 2019; 14(5):e0218032. PubMed ID: 31150525 [TBL] [Abstract][Full Text] [Related]
11. Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers. Gschwantler-Kaulich D; Weingartshofer S; Rappaport-Fürhauser C; Zeillinger R; Pils D; Muhr D; Braicu EI; Kastner MT; Tan YY; Semmler L; Sehouli J; Singer CF PLoS One; 2018; 13(4):e0196142. PubMed ID: 29664962 [TBL] [Abstract][Full Text] [Related]
12. Correction: Early Behavioral Abnormalities and Perinatal Alterations of PTEN/AKT Pathway in Valproic Acid Autism Model Mice. Yang EJ; Ahn S; Lee K; Mahmood U; Kim HS PLoS One; 2016; 11(6):e0157202. PubMed ID: 27258156 [TBL] [Abstract][Full Text] [Related]
13. Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? Gkika E; Vach W; Adebahr S; Schimek-Jasch T; Brenner A; Brunner TB; Kaier K; Prasse A; Müller-Quernheim J; Grosu AL; Zissel G; Nestle U PLoS One; 2018; 13(1):e0192058. PubMed ID: 29370272 [TBL] [Abstract][Full Text] [Related]
14. Correction: Optical imaging of ovarian cancer using a matrix metalloproteinase-3-sensitive near-infrared fluorescent probe. Wang KH; Wang YM; Chiu LH; Chen TC; Tsai YH; Zuo CS; Chen KC; Changou CA; Lai WT PLoS One; 2018; 13(8):e0202610. PubMed ID: 30107000 [TBL] [Abstract][Full Text] [Related]
15. Correction: PID1 alters the antilipolytic action of insulin and increases lipolysis via inhibition of AKT/PKA pathway activation. Yin C; Liu WH; Liu Y; Wang L; Xiao Y PLoS One; 2019; 14(6):e0218721. PubMed ID: 31206557 [TBL] [Abstract][Full Text] [Related]
16. Correction: Inhibition of Nickel Nanoparticles-Induced Toxicity by Epigallocatechin-3-Gallate in JB6 Cells May Be through Down-Regulation of the MAPK Signaling Pathways. Gu Y; Wang Y; Zhou Q; Bowman L; Mao G; Zou B; Xu J; Liu Y; Liu K; Zhao J; Ding M PLoS One; 2016; 11(4):e0154978. PubMed ID: 27124002 [TBL] [Abstract][Full Text] [Related]
17. Correction: MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer. PLOS ONE Editors PLoS One; 2020; 15(10):e0241462. PubMed ID: 33091075 [TBL] [Abstract][Full Text] [Related]
18. Correction: Familial risks of ovarian cancer by age at diagnosis, proband type and histology. Zheng G; Yu H; Kanerva A; Försti A; Sundquist K; Hemminki K PLoS One; 2018; 13(10):e0206721. PubMed ID: 30365548 [TBL] [Abstract][Full Text] [Related]
19. Correction: Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells. PLOS ONE Staff PLoS One; 2016; 11(5):e0155281. PubMed ID: 27145125 [TBL] [Abstract][Full Text] [Related]
20. Correction: PD-1 Blockade and OX40 Triggering Synergistically Protects against Tumor Growth in a Murine Model of Ovarian Cancer. Guo Z; Wang X; Cheng D; Xia Z; Luan M; Zhang S PLoS One; 2017; 12(10):e0186965. PubMed ID: 29045495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]